ArticlePregnancy (Hoboken, N.J.)2025
Associations of prenatal concentrations of environmental phthalates and phenols with preeclampsia.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Placental toxicity of alternative plasticizers: Current knowledge and future directions.Reproductive toxicology (Elmsford, N.Y.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Endocrine-disrupting chemicals (EDCs) like phthalates and phenols are ubiquitous in consumer products, raising concerns about fetal development and pregnancy complications such as hypertensive disorders of pregnancy (HDP). While usage of some EDCs is declining, substitutes with limited safety data are increasing. Prior research suggests a potential link between EDCs and HDP, but findings remain inconsistent. The objective of our study was to investigate the association between prenatal concentrations of phthalates, including replacements, and phenols and the risk of preeclampsia and gestational hypertension. Methods: We analyzed individual-level pooled data from 4050 singleton pregnant individuals in the Environmental Influences on Child Health Outcomes consortium. A total of 7836 urine samples, collected at least once during pregnancy, were analyzed for 13 phthalate metabolites and 11 phenols. The outcomes were preeclampsia and gestational hypertension. Generalized estimating equations models with Poisson distribution and robust variance, and quantile-based g-computation fit with four quantiles, were used to estimate relative risks (RR) with 95% confidence intervals (95%CI). Results: Significant associations with preeclampsia were found for a 1-IQR increase in urinary concentrations of specific phthalates and phenols, including di-2-ethylhexyl phthalate (DEHP) (aRR, 1.34 [95% CI, 1.17-1.54]), Di-n-octyl phthalate (DOP) (aRR, 1.22 [95% CI, 1.03-1.44]), bisphenol A (aRR, 1.20 [95% CI, 1.03-1.39]), bisphenols (aRR, 1.22 [95% CI, 1.03-1.45]), parabens (aRR, 1.52 [95% CI, 1.12-2.06]), and mixture of plastic additives and plasticizers (aRR, 1.40 [95% CI, 1.03-1.92]). No significant associations were observed with phthalate replacements, including di(isononyl) cyclohexane-1,2-dicarboxylate (DINCH) and di(2-ethylhexyl) terephthalate (DEHTP). Interaction studies showed stronger associations in male fetuses. No significant associations were identified of any phthalate or phenol concentrations with gestational hypertension. Conclusion: Results from this large US study raise the possibility that certain phthalate and phenol concentrations during pregnancy may be potentially modifiable risk factors for preeclampsia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.